A Dangerous Method: Correlations and proof of causation in vaccine related injuries

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In June 2017 the Court of Justice of the European Union (CJEU) handed down a complex decision on the liability of vaccine producers. The reference for a preliminary ruling stemmed from a French case in which a hepatitis B vaccine manufactured by Sanofi Pasteur allegedly caused personal injury to Mr W in the form of multiple sclerosis, a disease that ultimately led to his death.
The case is of particular significance as it presented the Court with an opportunity to clarify aspects of the causal link that a plaintiff needs to establish in order to be successful in a claim under the European Product Liability Directive (the Directive). This is the third decision in a series of recent judgments of the Court on the interpretation of several grey areas of the original text of the Directive. Sanofi comes after a clarification of the material scope of the Directive and its relationship to special liability systems provided under national laws in Novo Nordisk Pharma, and a revision of the concept of defect and defectiveness in cases involving complex technological products in Boston Scientific. This article contends that the decision in Sanofi endorses a dangerous method for the determination of a causal link between the administration of a vaccine and subsequent personal injury, whereby factual causation can effectively be reduced to speculative correlation.While there is undeniable value in vindicating the autonomy of legal reasoning in cases involving uncertain scientific issues, this should not result in arbitrariness.
Original languageEnglish
Number of pages19
JournalJournal of European Tort Law
Volume9
Issue number3
DOIs
Publication statusPublished - 21 Dec 2018

Fingerprint

liability
producer liability
multiple sclerosis
court of justice
contagious disease
producer
autonomy
Disease
death
interpretation
Law
Values

Cite this

@article{50ab538b251747249d9c0f0ae07871bd,
title = "A Dangerous Method: Correlations and proof of causation in vaccine related injuries",
abstract = "In June 2017 the Court of Justice of the European Union (CJEU) handed down a complex decision on the liability of vaccine producers. The reference for a preliminary ruling stemmed from a French case in which a hepatitis B vaccine manufactured by Sanofi Pasteur allegedly caused personal injury to Mr W in the form of multiple sclerosis, a disease that ultimately led to his death.The case is of particular significance as it presented the Court with an opportunity to clarify aspects of the causal link that a plaintiff needs to establish in order to be successful in a claim under the European Product Liability Directive (the Directive). This is the third decision in a series of recent judgments of the Court on the interpretation of several grey areas of the original text of the Directive. Sanofi comes after a clarification of the material scope of the Directive and its relationship to special liability systems provided under national laws in Novo Nordisk Pharma, and a revision of the concept of defect and defectiveness in cases involving complex technological products in Boston Scientific. This article contends that the decision in Sanofi endorses a dangerous method for the determination of a causal link between the administration of a vaccine and subsequent personal injury, whereby factual causation can effectively be reduced to speculative correlation.While there is undeniable value in vindicating the autonomy of legal reasoning in cases involving uncertain scientific issues, this should not result in arbitrariness.",
keywords = "Causation, VACCINE, Product liability, Torts",
author = "Marco Rizzi",
year = "2018",
month = "12",
day = "21",
doi = "10.1515/jetl-2018-0115",
language = "English",
volume = "9",
journal = "Journal of European Tort Law",
issn = "1868-9612",
number = "3",

}

A Dangerous Method : Correlations and proof of causation in vaccine related injuries. / Rizzi, Marco.

In: Journal of European Tort Law, Vol. 9, No. 3, 21.12.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A Dangerous Method

T2 - Correlations and proof of causation in vaccine related injuries

AU - Rizzi, Marco

PY - 2018/12/21

Y1 - 2018/12/21

N2 - In June 2017 the Court of Justice of the European Union (CJEU) handed down a complex decision on the liability of vaccine producers. The reference for a preliminary ruling stemmed from a French case in which a hepatitis B vaccine manufactured by Sanofi Pasteur allegedly caused personal injury to Mr W in the form of multiple sclerosis, a disease that ultimately led to his death.The case is of particular significance as it presented the Court with an opportunity to clarify aspects of the causal link that a plaintiff needs to establish in order to be successful in a claim under the European Product Liability Directive (the Directive). This is the third decision in a series of recent judgments of the Court on the interpretation of several grey areas of the original text of the Directive. Sanofi comes after a clarification of the material scope of the Directive and its relationship to special liability systems provided under national laws in Novo Nordisk Pharma, and a revision of the concept of defect and defectiveness in cases involving complex technological products in Boston Scientific. This article contends that the decision in Sanofi endorses a dangerous method for the determination of a causal link between the administration of a vaccine and subsequent personal injury, whereby factual causation can effectively be reduced to speculative correlation.While there is undeniable value in vindicating the autonomy of legal reasoning in cases involving uncertain scientific issues, this should not result in arbitrariness.

AB - In June 2017 the Court of Justice of the European Union (CJEU) handed down a complex decision on the liability of vaccine producers. The reference for a preliminary ruling stemmed from a French case in which a hepatitis B vaccine manufactured by Sanofi Pasteur allegedly caused personal injury to Mr W in the form of multiple sclerosis, a disease that ultimately led to his death.The case is of particular significance as it presented the Court with an opportunity to clarify aspects of the causal link that a plaintiff needs to establish in order to be successful in a claim under the European Product Liability Directive (the Directive). This is the third decision in a series of recent judgments of the Court on the interpretation of several grey areas of the original text of the Directive. Sanofi comes after a clarification of the material scope of the Directive and its relationship to special liability systems provided under national laws in Novo Nordisk Pharma, and a revision of the concept of defect and defectiveness in cases involving complex technological products in Boston Scientific. This article contends that the decision in Sanofi endorses a dangerous method for the determination of a causal link between the administration of a vaccine and subsequent personal injury, whereby factual causation can effectively be reduced to speculative correlation.While there is undeniable value in vindicating the autonomy of legal reasoning in cases involving uncertain scientific issues, this should not result in arbitrariness.

KW - Causation

KW - VACCINE

KW - Product liability

KW - Torts

U2 - 10.1515/jetl-2018-0115

DO - 10.1515/jetl-2018-0115

M3 - Article

VL - 9

JO - Journal of European Tort Law

JF - Journal of European Tort Law

SN - 1868-9612

IS - 3

ER -